Transcriptomic Comparisons of Somatic and Cancer Stem Cells

Area of Science:

• Oncology
• Stem Cell Biology
• Molecular Biology

Background:

• Stem cells are crucial for tissue repair, but their dysregulation leads to cancer stem cells (CSCs).
• CSCs drive tumor progression, metastasis, and resistance to therapy.
• A gap exists in understanding transcriptomic differences between normal somatic stem cells (SSCs) and CSCs.

Purpose of the Study:

• To synthesize current knowledge on stemness regulation in SSCs and CSCs.
• To highlight the divergence in transcriptomic landscapes between SSCs and CSCs.
• To provide a framework for developing targeted therapies against CSCs.

Main Methods:

• Review of key signaling pathways (Wnt, Notch, Hedgehog, TGF-β).
• Analysis of transcription factors (Oct4, Sox2, Nanog, c-Myc, YAP/TAZ).
• Examination of epigenetic mechanisms (chromatin remodeling, DNA methylation, microRNA).

Main Results:

• Identified key pathways, transcription factors, and epigenetic mechanisms governing stemness.
• Highlighted the role of EMT, cellular plasticity, and microenvironment in CSC phenotypes.
• Emphasized context-specific pathway modulation distinguishing regeneration from tumorigenesis.

Conclusions:

• Understanding transcriptomic and epigenetic differences is crucial for CSC-specific vulnerabilities.
• Targeted therapies can be developed to eliminate CSCs while preserving normal stem cell function.
• This knowledge advances precision oncology and minimizes damage to healthy tissues.